MicroRNA-500a promotes migration and invasion in hepatocellular carcinoma by activating the Wnt/b-catenin signaling pathway

被引:24
|
作者
Guo, Yuntao [1 ]
Chen, Liwen [1 ]
Sun, Chengyi [1 ]
Yu, Chao [1 ]
机构
[1] Guizhou Med Univ, Affiliated Hosp, Dept Hepatobiliary Surg, 28 Guiyi St, Guiyang 550004, Guizhou, Peoples R China
基金
中国国家自然科学基金; 对外科技合作项目(国际科技项目);
关键词
Hepatocellular carcinoma; miR-500a; Migration; Invasion; Wnt/b-catenin pathway; EPITHELIAL-MESENCHYMAL TRANSITION; CELL-PROLIFERATION; CANCER CELLS; BIOMARKER;
D O I
10.1016/j.biopha.2017.04.018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Increased expression of microRNA-500a (miR-500a) has been reported in the serum of hepatocellular carcinoma (HCC) patients. However, the biological effects and mechanisms of miR-500a in hepatoma cells remain unclear. In this study, we found that miR-500a expression was up-regulated in HCC cell lines and tissues, and that high levels of miR-500a was associated with poor prognosis. We found that miR500a upregulation promoted migration and invasion in two hepatoma cell lines, HCCLM3 and SMMC7721, while miR-500a downregulation had the opposite effect. We demonstrated that miR-500a activates the Wnt/beta-catenin signaling pathway by directly binding to the 3'-untranslated region (UTR) of SFRP2 and GSK-3 beta mRNA. In conclusion, our results indicate miR-500a promotes HCC migration and invasion through activating Wnt/beta-catenin signaling by directly binding to SFPR2 and GSK-3 beta. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 50 条
  • [41] miR-557 inhibits hepatocellular carcinoma progression through Wnt/B-catenin signaling pathway by targeting RAB10
    Cheng, Xiaoye
    Wu, Can
    Xu, Haocheng
    Zou, Ruixiang
    Li, Taiyuan
    Ye, Shanping
    AGING-US, 2024, 16 (04): : 3716 - 3733
  • [42] Gallic acid promotes ferroptosis in hepatocellular carcinoma via inactivating Wnt/β-catenin signaling pathway
    Jingyi Xie
    Haijiao Wang
    Wuxing Xie
    Yongping Liu
    Yi Chen
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 2437 - 2445
  • [43] DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway
    Tong Zhang
    Zhenjiang Ma
    Lijuan Liu
    Jian Sun
    Hui Tang
    Bing Zhang
    Ying Zou
    Heping Li
    Cell Death & Disease, 9
  • [44] DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway
    Zhang, Tong
    Ma, Zhenjiang
    Liu, Lijuan
    Sun, Jian
    Tang, Hui
    Zhang, Bing
    Zou, Ying
    Li, Heping
    CELL DEATH & DISEASE, 2018, 9
  • [45] Estradiol promotes cells invasion by activating β-catenin signaling pathway in endometriosis
    Xiong, Wenqian
    Zhang, Ling
    Yu, Lan
    Xie, Wei
    Man, Yicun
    Xiong, Yao
    Liu, Hengwei
    Liu, Yi
    REPRODUCTION, 2015, 150 (06) : 507 - 516
  • [46] RETRACTION: Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling
    Lin, Jie
    Lin, Wansong
    Ye, Yunbin
    Wang, Liping
    Chen, Xiaoyan
    Zang, Shengbing
    Huang, Aimin
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2025, 44 (01)
  • [47] The Role of Destrin Wnt/b-Catenin Signaling Pathway in Rectal Cancer Oncogenesis
    Ho, Vincent
    Callaghan, Cameron M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (01): : 211 - 213
  • [48] EFFECTS OF ASTRAGALOSIDE ON CHONDROCYTE PROLIFERATION BY REGULATING THE WNT/B-CATENIN SIGNALING PATHWAY
    Li, Zhuoze
    Zhang, Bin
    ACTA MEDICA MEDITERRANEA, 2021, 37 (06): : 3099 - 3104
  • [49] WNT/B-CATENIN SIGNALING PATHWAY IS ASSOCIATED WITH HYPERTENSIVE CARDIAC AND RENAL FIBROSIS
    Bogdanova, Evdokia
    Semenova, Natalia
    Galkina, Olga
    Zubina, Irina
    Beresneva, Olga
    Ivanova, Galina
    Parastaeva, Marina
    Dobronravov, Vladimir
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [50] Palladin promotes cancer stem cell-like properties in lung cancer by activating Wnt/B-Catenin signaling
    Shu, Xiong
    Chen, Meng
    Liu, Shi-Ya
    Yu, Long
    Sun, Li-Xin
    Sun, Li-Chao
    Ran, Yu-Liang
    CANCER MEDICINE, 2023, 12 (04): : 4510 - 4520